-Gregory Pontone, MD, Johns Hopkins School of Medicine
The Cosmopolitan of Las Vegas
3708 Las Vegas Blvd. S
Las Vegas, NV 89109
Industry
Register below if you are affiliated with a pharmaceutical company; device manufacturer; medical, healthcare education, or communications company; screening lab; or other BRAINWeek sponsor or exhibitor.
DO NOT register as a practicing healthcare professional, resident, or student. This information will be verified by BRAINWeek staff prior to confirmation of your registration.
Click here to register as a member of industry.
September 6-8, 2023
The current estimated annual cost to American society of just nine of the most common neurological diseases is staggering, totaling $789 billion. These conditions include Alzheimer’s disease and other dementias, low back pain, stroke, traumatic brain injury, migraine, epilepsy, multiple sclerosis, spinal cord injury, and Parkinson’s disease.
The 2023 conference faculty will be announced soon.
Alon Y. Avidan MD, MPH
Director, UCLA Sleep Disorders Center Professor & Vice Chair, UCLA Department of NeurologyGregory Pontone MD, MHS
Director, Parkinson’s Disease Neuropsychiatry ClinicJay Salpekar MD, FANPA, FAES, DFAACAP
Associate Professor of Psychiatry and NeurologyLindsey Wooliscroft MD, MSC, MCR
Assistant Professor of Neurology*Courses are subject to change
Wednesday, September 6
Cannabinoids are varied in terms of products available and have multiple roles in the central nervous system. During this session, an updated overview of the endocannabinoid system and potential targets of therapeutic agents will be provided. Epilepsy is a common illness that has proven to improve with use of cannabinoids. Treatment approaches are challenging given the lack of available data and the uncertain quality of products. However, the therapeutic potential of these agents for epilepsy and in other conditions is vast and will be explored during this section.
Faculty: Jay Salpekar, MD
Thursday, September 7
Cannabinoids are varied in terms of products available and have multiple roles in the central nervous system. During this session, an updated overview of the endocannabinoid system and potential targets of therapeutic agents will be provided. Epilepsy is a common illness that has proven to improve with use of cannabinoids. Treatment approaches are challenging given the lack of available data and the uncertain quality of products. However, the therapeutic potential of these agents for epilepsy and in other conditions is vast and will be explored during this section.
Faculty: Jay Salpekar, MD
Friday, September 8
Cannabinoids are varied in terms of products available and have multiple roles in the central nervous system. During this session, an updated overview of the endocannabinoid system and potential targets of therapeutic agents will be provided. Epilepsy is a common illness that has proven to improve with use of cannabinoids. Treatment approaches are challenging given the lack of available data and the uncertain quality of products. However, the therapeutic potential of these agents for epilepsy and in other conditions is vast and will be explored during this section.
Faculty: Jay Salpekar, MD
Cannabinoids are varied in terms of products available and have multiple roles in the central nervous system. During this session, an updated overview of the endocannabinoid system and potential targets of therapeutic agents will be provided. Epilepsy is a common illness that has proven to improve with use of cannabinoids. Treatment approaches are challenging given the lack of available data and the uncertain quality of products. However, the therapeutic potential of these agents for epilepsy and in other conditions is vast and will be explored during this section.
Faculty: Jay Salpekar, MD
DEADLINE for submission is 11:59p ET, Friday, June 30, 2023. All authors will be notified via email on or by August 11, 2023.
BRAINWeek invites you to submit abstracts for posters to be presented at the 2023 BRAINWeek National Conference. Please review the guidelines below.
Abstracts may be research oriented, or evidence based, and relevant to specialists and frontline practitioners who manage CNS disorders. They may include medication management, devices, and digital therapeutics. Abstracts may be a summary of research findings or a review of current evidence-based recommendations for clinical applications that are pertinent to frontline practitioners and specialists who treat CNS patients.
Abstract Guidelines
Disclosures: BRAINWeek requires faculty and poster authors/presenters who have an interest in selling a technology, program, product, and/or service to healthcare professionals to disclose this information in order to be considered for and/or present at any BRAINWeek educational session.
Publication: If your abstract is accepted, you will be notified on or by August 11, and the abstract will be posted online by August 30. Only accepted abstracts will be posted online. Posters will not be published online.
Convening September 6-8, BRAINWeek was developed by the PAINWeek organization—now in its 17th year of exceptional pain management education—and will provide live activities addressing the most frequently diagnosed conditions encountered in clinical practice, with an emphasis on collaborative care among specialists and frontline practitioners.
You can be one of 10 frontline practitioners to receive a complimentary registration for this year’s conference. We ask that you compose a compelling essay explaining why BRAINWeek would be beneficial for your professional area of focus.
All essays must be received by 11:59p ET on July 7, 2023.
Scholarship winners will be notified via email and/or phone no later than August 4, 2023. Winners must respond by
August 19, 2023.
Scholarship applicants must be:
Scholarship applicants may NOT be:
Essay requirements:
Conference Venue
3708 Las Vegas Blvd. S
Las Vegas, NV 89109
Phone Number: (702) 698-7000
Excitement is building for BRAINWeek coming to Las Vegas in September! As such, we encourage you to complete your room reservation as early as possible, as the room block will fill up quickly. Please note the following information and proceed as directed.
BRAINWeek has secured an incredible discounted rate of $189/night + tax and mandatory resort fee of $10/day + tax at The Cosmopolitan of Las Vegas. The tax rate for Las Vegas is 13.38%.
Join this year’s illustrious lineup of brand partners and take your 2023 goals to next level.
Cancellations must be submitted in writing. If you are calling to cancel, for verification we will still require you to send an email to info@brainweek.org with your intent to cancel. You will receive confirmation of your cancellation via email.
We will offer a 100% refund within 72 hours from the time of purchase less $100 credit card processing fee.
BRAINWeek
1801 N. Military Trail Suite 110
Boca Raton, Florida 33431
Copyright © 2023, BRAINWeek. All trademarks, registered or unregistered, are the property of their respective owners.
Automated page speed optimizations for fast site performance